Global Fluorescent in Situ Hybridization (FISH) Probe Market to Reach US$ 1,512.7 Million by 2032, Facilitated by Surging Need for In Vitro Diagnostics (IVD) Testing

October 10, 2022 | Healthcare

IMARC Group’s latest report, titled “Fluorescent in Situ Hybridization (FISH) Probe Market Report by Type (DNA, RNA), Probe Type (Locus Specific Probes, Alphoid/Centromeric Repeat Probes, Whole Chromosome Probes), Technology (Flow FISH, Q FISH, and Others), Application (Cancer, Genetic Diseases, and Others), End-User (Research Organizations, Diagnostic Centers, and Others), and Region 2024-2032,” finds that the global fluorescent in situ hybridization (FISH) probe market reached a value of US$ 872.9 Million in 2023. Fluorescent in Situ Hybridization, or FISH, is a laboratory technique that helps locate specific DNA sequences, diagnose genetic diseases, map genes, and detect novel oncogenes or genetic aberrations. It relies on fluorescent probes to visualize genetic materials as these probes absorb light of a particular wavelength and emit light upon binding with a specific DNA or RNA sequence, resulting in colored signals that can be detected using a fluorescent microscope. In recent years, FISH probes have gained immense traction due to their excellent sensitivity and accuracy in identifying targeted sequences, direct application to both metaphase chromosomes and interphase nuclei, and accurate visualization of hybridization signals at the single-cell level.

Global Fluorescent in Situ Hybridization (FISH) Probe Market Trends:

The surging need for In Vitro Diagnostics (IVD) testing and targeted therapies due to the rising incidences of various genetic and chronic diseases represent the primary factor driving the market growth. Compared to the standard cytogenetic (cell gene) tests, FISH tests can detect minute genetic changes that are generally missed under the microscope. As a result, the growing usage of FISH probes for the diagnosis, prediction of outcomes, and clinical management of cancer and genetic disorders is contributing to market growth. Besides this, the escalating demand for rapid, sensitive, and accurate prognosis techniques for disease validation is another major growth-inducing factor. Additionally, the leading players are engaging in research and development (R&D) activities to introduce novel disease-specific biomarkers. In line with this, continual product innovations, such as the development of FISH probes with higher sensitivity and accuracy, have propelled market growth. Other factors, including the rapid automation of diagnostic tests, favorable reimbursement policies, increasing healthcare expenditure, extensive investments in pharmacogenomics and pharmaceutical research, and advancements in biotechnology, are creating a positive market outlook. Looking forward, IMARC Group expects the market value to reach US$ 1,512.7 Million by 2032, expanding at a CAGR of 6.1% during 2024-2032.

Market Summary:

  • Based on the type, the market has been bifurcated into DNA and RNA (mRNA, miRNA, and others). 
  • On the basis of the probe type, the market has been classified into locus-specific, alphoid/centromeric repeat, and whole chromosome probes. 
  • The market has been segmented based on technology into flow FISH, Q FISH, and others. 
  • Based on the application, the market has been categorized into cancer, genetic diseases, and others. 
  • On the basis of the end user, the market has been segregated into research organizations, diagnostic centers, and others. 
  • Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being Abnova Corporation, Agilent Technologies Inc., Biocare Medical LLC, Biosearch Technologies Inc. (LGC Ltd.), Creative Biolabs Inc., F. Hoffmann-La Roche Ltd. (Roche Holding AG), Genemed Biotechnologies Inc. (Sakura Finetek USA Inc.), Merck KGaA, Oxford Gene Technology IP Limited (Sysmex Corporation), PerkinElmer Inc., and ThermoFisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Segment Coverage Type, Probe Type, Technology, Application, End-User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abnova Corporation, Agilent Technologies Inc., Biocare Medical LLC, Biosearch Technologies (LGC Ltd.), Creative Biolabs, F. Hoffmann-La Roche Ltd. (Roche Holding AG), Genemed Biotechnologies Inc. (Sakura Finetek USA Inc.), Merck KGaA, Oxford Gene Technology (Sysmex Corporation), PerkinElmer Inc. and ThermoFisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Fluorescent in Situ Hybridization (FISH) Probe Market to Reach US$ 1,512.7 Million by 2032, Facilitated by Surging Need for In Vitro Diagnostics (IVD) Testing
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More